Literature DB >> 26221337

Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma.

Tingting Zhang1, Dan Su1, Zhiyuan Mao1, Xiaochuan Guo1, Lijie Wang1, Li Bai1.   

Abstract

The objective of the current study was to investigate the significance and biologic characteristic of neuroendocrine cell differentiation (NED) in gastric carcinoma by comparing the prognosis and clinicopathologic characteristics between patients with or without NED. Retrospective analyses of neuroendocrine markers, neuron specific enolase (NSE), chromogranin A (CgA), and synaptophysin (Syn) were performed in 174 human gastric carcinoma patients. NED association was found in 21.3% gastric carcinoma patients, with or without NED, and was correlated with tumor location, cancer emboli, infiltrative depth, TNM stage and distant metastasis (P < 0.05 in each case). The 1-year and 3-year survival rate of the patients who suffered from gastric carcinoma with NED were significantly lower than those without NED. The overall survival time of patients with NED was shorter than those with gastric carcinoma without NED, with a significant difference between the two types (P = 0.037). Cumulatively, gastric carcinoma patients with NED had shorter postoperative survival time and poorer prognosis.

Entities:  

Keywords:  Gastric carcinoma; chromogranin A; neuroendocrine differentiation; neuron specific enolase; prognosis; synaptophysin

Year:  2015        PMID: 26221337      PMCID: PMC4509282     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  7 in total

1.  Gastric cancer histology: clinicopathologic characteristics and prognostic value.

Authors:  Joong-Min Park; You-Jin Jang; Jong-Han Kim; Sung-Soo Park; Seong-Heum Park; Seung-Joo Kim; Young-Jae Mok; Chong-Suk Kim
Journal:  J Surg Oncol       Date:  2008-12-01       Impact factor: 3.454

2.  Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreactive chromogranin A and its biologic significance.

Authors:  A Ooi; M Mai; T Ogino; H Ueda; T Kitamura; Y Takahashi; E Kawahara; I Nakanishi
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

3.  Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique.

Authors:  G Qvigstad; A K Sandvik; E Brenna; S Aase; H L Waldum
Journal:  Histochem J       Date:  2000-09

4.  Cancer of the stomach. A patient care study by the American College of Surgeons.

Authors:  H J Wanebo; B J Kennedy; J Chmiel; G Steele; D Winchester; R Osteen
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

Review 5.  Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms.

Authors:  Marco Volante; Luisella Righi; Sofia Asioli; Gianni Bussolati; Mauro Papotti
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

6.  Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.

Authors:  Funda Eren; Ciğdem Celikel; Bahadir Güllüoğlu
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

7.  Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.

Authors:  Pinar Atasoy; Arzu Ensari; Salim Demirci; Nazmiye Kurşun
Journal:  Tumori       Date:  2003 Jan-Feb
  7 in total
  7 in total

1.  Clinicopathological Characteristics and Prognostic Factors of Patients with Gastric Cancer Accompanying Neuroendocrine Differentiation (NEDGC).

Authors:  Ya-Ping Wang; Jun Hong; Jian Wang; Yi-Bing Bei; Han-Kun Hao; Lu-Chun Hua
Journal:  Cancer Manag Res       Date:  2020-06-03       Impact factor: 3.989

2.  Α-fetoprotein producing hepatoid gastric adenocarcinoma with neuroendocrine differentiation: A case report.

Authors:  Tao Li; Tongjun Liu; Min Wang; Mingwei Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

3.  Gastric adenocarcinoma is concurrent with metastatic neuroendocrine cancer treated with nivolumab and chemotherapy: A case report.

Authors:  Bing Yan; Meiqi Cui; Junhao You; Fang Li; Hui Liu
Journal:  Mol Clin Oncol       Date:  2018-10-05

4.  The Significant Influence of the Neuroendocrine Component on the Survival of Patients with Gastric Carcinoma Characterized by Coexisting Exocrine and Neuroendocrine Components.

Authors:  Hu Ren; Su-Sheng Shi; Nian-Chang Wang; Xing Wang; Ying-Tai Chen; Dong-Bing Zhao
Journal:  J Oncol       Date:  2019-03-12       Impact factor: 4.375

5.  Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases.

Authors:  Yi Zou; Linying Chen; Xingfu Wang; Yupeng Chen; Liwen Hu; Saifan Zeng; Pengcheng Wang; Guoping Li; Ming Huang; Liting Wang; Shi He; Sanyan Li; Lihui Jian; Sheng Zhang
Journal:  J Gastric Cancer       Date:  2019-03-20       Impact factor: 3.720

6.  Correlation study between serum neuro-specific enolase and gastric and colorectal cancers.

Authors:  Hai Luo; Kexin Shen; Hongyan Sun; Ruiqi Li; Zeming Wang; Zhongshi Xie
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

7.  Clinical significance of serum neuron-specific enolase in gastric adenocarcinoma.

Authors:  Hai Luo; Kexin Shen; Hongyan Sun; Ruiqi Li; Zeming Wang; Zhongshi Xie
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.